|
ZNF259 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.68259978067442E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.17460485782317E-11 |
| Normal-vs-Stage2 |
1.881450E-03 |
| Normal-vs-Stage3 |
1.499150E-03 |
| Normal-vs-Stage4 |
8.45230000000585E-05 |
| Stage1-vs-Stage2 |
1.413610E-01 |
| Stage1-vs-Stage3 |
2.742000E-02 |
| Stage1-vs-Stage4 |
7.846600E-01 |
| Stage2-vs-Stage3 |
7.220800E-01 |
| Stage2-vs-Stage4 |
3.986400E-01 |
| Stage3-vs-Stage4 |
1.919240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.69330163411064E-11 |
| Normal-vs-AfricanAmerican |
4.523900E-02 |
| Normal-vs-Asian |
4.638600E-01 |
| Caucasian-vs-AfricanAmerican |
4.081800E-02 |
| Caucasian-vs-Asian |
2.346600E-01 |
| AfricanAmerican-vs-Asian |
7.039600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52219999938197E-08 |
| Normal-vs-Female |
1.75820003001093E-09 |
| Male-vs-Female |
3.182800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.466500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.51090000510834E-08 |
| Normal-vs-Age(61-80Yrs) |
7.77719999511817E-09 |
| Normal-vs-Age(81-100Yrs) |
1.772430E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.893400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.589800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.173400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.196600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.330600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.621800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.8476000000065E-05 |
| Normal-vs-Grade 2 |
1.10510001150033E-09 |
| Normal-vs-Grade 3 |
2.011199999985E-06 |
| Normal-vs-Grade 4 |
2.229200E-04 |
| Grade 1-vs-Grade 2 |
3.181800E-01 |
| Grade 1-vs-Grade 3 |
2.039000E-01 |
| Grade 1-vs-Grade 4 |
6.414200E-01 |
| Grade 2-vs-Grade 3 |
2.298800E-01 |
| Grade 2-vs-Grade 4 |
6.894200E-01 |
| Grade 3-vs-Grade 4 |
3.036400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63202784619898E-12 |
| Normal-vs-ccB subtype |
1.786970E-04 |
| ccA subtype-vs-ccB subtype |
2.166600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.14190000180636E-08 |
| Normal-vs-N1 |
1.912000E-01 |
| N0-vs-N1 |
4.424000E-01 |
|
|
